Five-year results of prognostic value of tyrosinase in peripheral blood of uveal melanoma patients

Melanoma Research

Volumn 15, Issue 6, 2005, Pages 503-507

  Boldin, Ingrid ^a   Langmann, Gerald ^a   Richtig, Eva ^a   Schwantzer, Gerold ^b   Ardjomand, Navid ^a   Wegscheider, Beate ^a   El Shabrawi, Yosuf ^a,b  

^a UNIVERSITY HOSPITAL GRAZ   (Austria)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Melanoma; Metastasis; Polymerase chain reaction; Survival rate; Tyrosinase; Uveal

Indexed keywords

LIVER ENZYME; MESSENGER RNA; MONOPHENOL MONOOXYGENASE; RUTHENIUM;

ADULT; AGED; ARTICLE; BLOOD CELL; BLOOD SAMPLING; BONE SCINTISCANNING; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; ENZYME ASSAY; ENZYME BLOOD LEVEL; FEMALE; FOLLOW UP; GAMMA KNIFE RADIOSURGERY; HEPATOGRAPHY; HISTOCHEMISTRY; HISTOPATHOLOGY; HUMAN; HYPERTHERMIC THERAPY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; THORAX RADIOGRAPHY; TUMOR LOCALIZATION; TUMOR VOLUME; UVEA MELANOMA; BLOOD; DISEASE COURSE; ENZYMOLOGY; GENETICS; MELANOMA; MIDDLE AGED; PATHOLOGY; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR EMBOLISM; UVEA TUMOR;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MELANOMA; MIDDLE AGED; MONOPHENOL MONOOXYGENASE; NEOPLASM CIRCULATING CELLS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; TREATMENT OUTCOME; UVEAL NEOPLASMS;

EID: 33646968547     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200512000-00004     Document Type: Article

References (25)

1. Singh AD, Topham A. Incidence of uveal melanoma in the United States: 1973-1997. Ophthalmology 2003; 110:956-961.
2. Singh AD, Topham A. Survival rates with uveal melanoma in the United States: 1973-1997. Ophthalmology 2003; 110:962-965.
3. Seddon JM, Gragoudas ES, Egan KM, Glynn RJ, Howard S, Fante RG et al. Relative survival rates after alternative therapies for uveal melanoma. Ophthalmology 1990; 97:769-777.
4. Kroll S, Char DH, Quivey J, Castro J. A comparison of cause-specific melanoma mortality and all-cause mortality in survival analyses after radiation treatment for uveal melanoma. Ophthalmology 1998; 105:2035-2045.
5. Char DH, Quivey JM, Castro JR, Kroll S, Phillips T. Helium ions versus iodine 125 brachytherapy in the management of uveal melanoma. A prospective, randomized, dynamically balanced trial. Ophthalmology 1993; 100:1547-1554.
6. Singh AD, Shields CL, Shields JA. Prognostic factors in uveal melanoma. Melanoma Res 2001; 11:255-263.
7. Smith B, Selby P, Southgate J, Pittman K, Bradley C, Blair GE. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 1991; 338:1227-1229.
8. Tsao H, Nadiminti U, Sober AJ, Bigby M. A meta-analysis of reverse transcriptase-polymerase chain reaction for tyrosinase mRNA as a marker for circulating tumor cells in cutaneous melanoma. Arch Dermatol 2001; 137:325-330.
9. Tobal K, Sherman LS, Foss AJ, Lightman SL. Detection of melanocytes from uveal melanoma in peripheral blood using the polymerase chain reaction. Invest Ophthalmol Vis Sci 1993; 34:2622-2625.
10. Foss AJ, Guille MJ, Occleston NL, Hykin PG, Hungerford JL, Lightman S. The detection of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction. Br J Cancer 1995; 72:155-159.
11. Keilholz U, Goldin-Lang P, Bechrakis NE, Max N, Letsch A, Schmittel A, et al. Quantitative detection of circulating tumor cells in cutaneous and ocular melanoma and quality assessment by real-time reverse transcriptase-polymerase chain reaction. Clin Cancer Res 2004; 10:1605-1612.
12. El-Shabrawi Y, Langmann G, Hutter H, Kenner L, Hoefler G. Comparison of current methods and PCR for the diagnosis of metastatic disease in uveal malignant melanoma. Ophthalmologica 1998; 212:80.
13. Ossoinig KC. Standardized echography: basic principles, clinical applications, and results. Int Ophthalmol Clin 1979; 19:127-210.
14. Dibernardo CW, Schachat AP, Fekrat S. Intraocular tumors. In: Dibernardo CW, Schachat AP, Fekrat S, editors. Ophthalmic ultrasound - a diagnostic atlas. New York, Stuttgart: Thieme; 1998, pp. 87-107.
15. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma II: initial mortality findings. COM3 report no. 10. Am J Ophthalmol 1998; 125:779-796.
16. Reinhold U, Berkin C, Bosserhoff AK, Deutschmann A, Garbe C, Glaser R, et al. Interlaboratory evaluation of a new reverse transcriptase polymerase chain reaction-based enzyme-linked immunosorbent assay for the detection of circulating melanoma cells: a multicenter study of the Dermatologic Cooperative Oncology Group. J Clin Oncol 2001; 19:1723-1727.
17. Farthmann B, Eberle J, Krasagakis K, Gstottner M, Wang N, Bisson S, et al. RT-PCR for tyrosinase-mRNA-positive cells in peripheral blood: evaluation strategy and correlation with known prognostic markers in 123 melanoma patients. J Invest Dermatol 1998; 110:263-267.
18. Mortality in patients with small choroidal melanoma. COMS report no. 4. The Collaborative Ocular Melanoma Study Group. Arch Ophthalmol 1997; 115:886-893.
19. Rochels R, Nover A, Adam F. Untersuchungen zur Schallreflektivität und -schwächung in Aderhautmelanomen. Graefes Arch Clin Exp Ophthalmol 1982; 218:37-38.
20. Freyler H, Egerer I. Echography and histological studies in various eye conditions. Arch Ophthalmol 1977; 95:1387-1394.
21. Rosa N, Cennamo G, Tranfa F. Comparison between echographic and histological findings in choroidal malignant melanomas. Acta Ophthalmol 1992; Suppl. 204:99-101.
22. Reinhold U, Ludtke-Handjery HC, Schnautz S, Kreysel HW, Abken H. The analysis of tyrosinase-specific mRNA in blood samples of melanoma patients by RT-PCR is not a useful test for metastatic tumor progression. J Invest Dermatol 1997; 108:166-169.
23. Zimmerman LE, McLean IW. An evaluation of enucleation in the management of uveal melanomas. Am J Ophthalmol 1979; 87:741-760.
24. Diener-West M, Earle JD, Fine SL, Hawkins BS, Moy CS, Reynolds SM, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS report no. 18. Arch Ophthalmol 2001; 119:969-982.
25. El Shabrawi Y, Ardjomand N, Radner H. MMP-9 is predominantly expressed in epithelioid and not spindle cell uveal melanoma. J Pathol 2001; 194:201-206.